Telesis Bio Investor Relations Material
Latest events
Q2 2023
Telesis Bio
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Telesis Bio Inc
Access all reports
Telesis Bio Inc., formerly Codex DNA, Inc., is a synthetic biology company. The Company designs and sells synthetic biology instruments, reagents, plasmids and associated products and services primarily to pharmaceutical and academic laboratories. Codex's platform focuses on building the industry's most powerful research automation instrumentation designed for DNA synthesis, purification and analysis in support of therapeutic development.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States